Qualifications for allergen specific immunotherapy – an algorithm

Marek L. Kowalski

doi:10.5114/pja.2018.78590

eISSN: 2391-6052
ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Publication charge Supplements Special issues Instructions for authors Publication charge

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2018
vol. 5

Send email

Copy url:

abstract:

Guidelines/recommendations

Qualifications for allergen specific immunotherapy – an algorithm

Marek L. Kowalski

Alergologia Polska – Polish Journal of Allergology 2018; 5, 3: 129–132

DOI: https://doi.org/10.5114/pja.2018.78590

Online publish date: 2018/09/25

View full text Get citation

PlumX metrics:

Allergen immunotherapy (AIT) is effective in patients with allergic respiratory symptoms related to IgE-mediated sensitization; effectiveness of pharmacological treatment and potential risk/benefit ratio should be assessed before the AIT is started. Effectiveness of AIT has been documented in patients with allergic rhinitis and conjunctivitis, atopic asthma, and Hymenoptera venom allergy. To facilitate qualification of a patient with respiratory symptoms for AIT, we propose to follow four steps algorithm, which includes: fulfillment by a patient of basic criteria (symptomatic, IgE-mediated allergy), assessment of effectiveness probability, chances for preventive effects and lack of contraindications to immunotherapy.

keywords:

Qualifications for allergen specific immunotherapy – an algorithm

Marek L. Kowalski

allergen-specific immunotherapy, allergic rhinits, bronchial asthma